Several investigational drug trials were presented at The Liver Meeting 2011 -- the annual meeting of the American Association for the Study of Liver Diseases. Two groups reported the apparently ...
PHILADELPHIA, Dec. 20, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") announced that the Company has entered into an agreement with GP Pharm ...
Please provide your email address to receive an email when new articles are posted on . Upon its discovery in 1989, the only treatment for hepatitis C was interferon. Later, ribavirin was added, and ...
FRESNO, Calif. (KFSN) -- About 3.2 million Americans are living with hepatitis C. It was once considered a death sentence -- but now, new therapies are offering a cure for many. Roger Warmuth loves ...
Interferon-Free Treatment: No Longer a Dream? Several studies were presented at both Digestive Disease Week (DDW) 2012 in May and at the European Association for the Study of the Liver (EASL) annual ...
HAVANA—Communist-run Cuba, laboring under a six-decade U.S. embargo, is betting a biotech sector begun by late revolutionary leader Fidel Castro can give the Caribbean island an edge in a global race ...
BOSTON (AP) _ Quick treatment after infection can almost always cure hepatitis C, a condition that causes between 8,000 and 10,000 deaths in the United States each year, according to a study released ...
Figure 1. The direct-acting antiviral targets in the hepatitis C virus replication cycle. NS3/4A protease inhibitors target the NS3/4A protease enzyme which is needed for the virus to develop the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback